The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

Haitao Yang(Institute of Biophysics), Maojun Yang(Institute of Biophysics), Yi Ding(Institute of Biophysics), Yiwei Liu(Institute of Biophysics), Zhiyong Lou(Institute of Biophysics), Zhe Zhou(Institute of Biophysics), Lei Sun(Institute of Biophysics), Lijuan Mo(Institute of Biophysics), Sheng Ye(Institute of Biophysics), Hai Pang(Institute of Biophysics), George F. Gao(Institute of Biophysics), K. Anand(Institute of Biophysics), Mark Bartlam(Institute of Biophysics), R. Hilgenfeld(Institute of Biophysics), Zihe Rao(Institute of Biophysics)
Proceedings of the National Academy of Sciences
October 29, 2003
Cited by 1,056Open Access
Full Text

Abstract

A newly identified severe acute respiratory syndrome coronavirus (SARS-CoV), is the etiological agent responsible for the outbreak of SARS. The SARS-CoV main protease, which is a 33.8-kDa protease (also called the 3C-like protease), plays a pivotal role in mediating viral replication and transcription functions through extensive proteolytic processing of two replicase polyproteins, pp1a (486 kDa) and pp1ab (790 kDa). Here, we report the crystal structures of the SARS-CoV main protease at different pH values and in complex with a specific inhibitor. The protease structure has a fold that can be described as an augmented serine-protease, but with a Cys-His at the active site. This series of crystal structures, which is the first, to our knowledge, of any protein from the SARS virus, reveal substantial pH-dependent conformational changes, and an unexpected mode of inhibitor binding, providing a structural basis for rational drug design.


Related Papers

No related papers found

Powered by citation graph analysis